Cannabis 2.0 Extractors and psychedelic prospectors featured at KCSA investor conference Earnings leader Valens was a highlight at the one-day virtual event Nick LabaApril 20, 2020
News Psychedelic conference weighs treatment efficacy against mainstream viability Medical and therapeutic benefits are clear even if scalability isn't Michelle GamageApril 16, 2020
The weed wire Champignon Brands grows research cap with AltMed acquisition The psychedelic medicine company has surged since going public last month and is quickly expanding its research footprint Jared GnamApril 13, 2020
News McGill researchers find you can have a psychedelic experience without taking any drugs Study found 61 per cent of participants felt a psychedelic-like high after taking placebo pill Michelle GamageApril 2, 2020
Cannabis 2.0 Hang tight, better times are coming: Lift & Co expo day 1 The three-day convention kicked off on a positive note at the business conference Michelle GamageJanuary 9, 2020
Enforcement Have fun without a hospital trip, says Safer Partying campaign Drug Policy Alliance calls for harm reduction over the holidays Michelle GamageDecember 27, 2019
Canada Canopy Founder Bruce Linton Joins Two Pot Firms, Sees Big Opportunity in Psychedelics At nearly the exact time Canopy announced its CEO hiring plans, Linton revealed he's joining two U.S. cannabis companies and one Toronto based medical... Jared GnamSeptember 20, 2019